James F. Dempsey - Jun 10, 2022 Form 3 Insider Report for ViewRay, Inc. (VRAYQ)

Role
Chief Scientific Officer
Signature
/s/ Robert McCormack, Attorney-in-fact
Stock symbol
VRAYQ
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
3
Date filed
3/21/2023, 06:22 PM
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VRAYQ Common Stock 680K Jun 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRAYQ Stock Option (right to buy) Jun 10, 2022 Common Stock 334K $0.75 Direct F2
holding VRAYQ Stock Option (right to buy) Jun 10, 2022 Common Stock 273K $5.00 Direct F3
holding VRAYQ Stock Option (right to buy) Jun 10, 2022 Common Stock 200K $5.05 Direct F4
holding VRAYQ Stock Option (right to buy) Jun 10, 2022 Common Stock 110K $7.09 Direct F5
holding VRAYQ Stock Option (right to buy) Jun 10, 2022 Common Stock 66.9K $8.47 Direct F6
holding VRAYQ Performance Units Jun 10, 2022 Common Stock 51.5K Direct F7, F8
holding VRAYQ Performance Units Jun 10, 2022 Common Stock 84.5K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 497,224 shares granted as RSUs. As of the transaction date, 189,463 of the RSUs have vested.
F2 Of which 96,149 shares vest in 48 monthly installments beginning on May 13, 2013, until such shares subject to the option have become fully vested and exercisable. The remaining 238,156 shares will vest 25% on the first anniversary of November 13, 2013 (the grant date), and 1/48th of the total number of shares vest in thirty-six (36) monthly installments thereafter on each monthly anniversary of the grant date, until such shares subject to the option have become fully vested and exercisable.
F3 The shares subject to the option vest in 48 monthly installments on each monthly anniversary of July 23, 2015, until such shares subject to the option have become fully vested and exercisable.
F4 1/48th of the shares subject to the option shall vest and become exercisable on each monthly anniversary measured from February 18, 2017 (the grant date), such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person remaining a service provider through each such vesting date.
F5 1/48th of the shares subject to the option shall vest and become exercisable on each monthly anniversary measured from April 16, 2018 (the grant date), such that 100% of the shares subject to the option will be vested on the fourth anniversary of the grant date, subject to the Reporting Person remaining a service provider through each such vesting date.
F6 1/48th of the shares subject to the option shall vest and become exercisable on each month after March 1, 2019 (the grant date), such that 100% of the shares subject to the option will be vested on the fourth anniversary of the grant date, subject to the reporting person remaining a service provider through each such vesting date.
F7 These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled.
F8 Not applicable